LEADERSHIP AND STRATEGY

Pharma Nobis, LLC Acquires Fagron's Contract Manufacturing Business and Manufacturing Facility, Appoints Todd Daviau CEO

Pharma Nobis | February 07, 2022

Pharma Nobis, LLC Acquires Fagron's
On February 4, an investment consortium led by Signet Healthcare Partners, Bionpharma, Inc., and GMS Capital Partners LLC announced the formation of Pharma Nobis, LLC to acquire Fagron's contract manufacturing business in the United States. Based in Texarkana, Texas, this business unit offers contract manufacturing and private-label services to consumer healthcare firms and retailers throughout the United States. Fagron will maintain a 20% stake in the company. The CEO of Pharma Nobis is Todd Daviau, a co-founder and former President and CEO of CoreRx, a well-known contract development, and manufacturing company. He has been named CEO of Pharma Nobis.

James Gale, Managing Director at Signet Healthcare Partners, noted, We are enthused about the opportunity to invest in this business. Fagron has developed into an outstanding company with a reputation as a cost-competitive manufacturer with a high service rating. We and our equity partners will seek to build on this capability and support the Pharma Nobis management team in growing their business.

"I appreciate the opportunity to work with the Signet investment team again and am excited about this opportunity to take Pharma Nobis to the next level in personal care manufacturing. We will seek to serve our customer base through reliable service and innovation."

-The CEO of Pharma Nobis is Todd Daviau

Along with Todd Daviau, James Gale, Dr. Theron Odlaug, Yezan Haddadin, and Andrew Pulido will join the company's Board of Directors, which was announced in conjunction with the acquisition. Dr. Odlaug is a seasoned executive in the pharmaceutical industry and a Signet Venture Partner. GMS Capital Partners LLC is led by Yezan Haddadin. Fagron North America is led by Andrew Pulido. Troutman Pepper served as the acquiring syndicate's legal counsel.

Spotlight

Additive Manufacturing (AM) has been there for many decades now. It has seen greater attention and wide spread awareness in the past few years due to affordable machines, innovative materials
and the rise of AM service providers. Today AM has a footprint in all major industries – from
aerospace and automotive to medical implants and fashion. Additive manufacturing refers to a
process by which digital 3D design data is used to build up a component in layers by depositing
material

Spotlight

Additive Manufacturing (AM) has been there for many decades now. It has seen greater attention and wide spread awareness in the past few years due to affordable machines, innovative materials
and the rise of AM service providers. Today AM has a footprint in all major industries – from
aerospace and automotive to medical implants and fashion. Additive manufacturing refers to a
process by which digital 3D design data is used to build up a component in layers by depositing
material

Related News

ADDITIVE MANUFACTURING

Shapeways Strengthens Quality Management to Meet the Stringent Demands of Additive Manufacturing 2.0

Shapeways | January 21, 2022

Shapeways Holdings, Inc., a worldwide leader in digital manufacturing powered by proprietary software, is expanding its comprehensive quality assurance capabilities to fulfill the stringent production needs of business clients while also meeting the new demands of additive manufacturing 2.0. This new generation of 3D printing represents a tipping point on the path to widespread adoption, which Shapeways is facilitating with its world-class services and support for a varied range of demanding additive manufacturing applications. With its end-to-end digital manufacturing platform and extensive network of manufacturing partners, Shapeways is perfectly positioned to assist in creating market momentum for Additive Manufacturing 2.0.Shapeways' expanded quality assurance capabilities are meant to minimize production obstacles while enhancing the speed with which over one million customers globally get high-quality components and products. "Quality is at the heart of all we do—from refining initial designs to delivering final products and every step in-between, We continually enhance our quality systems, which are designed to ensure that we meet our customers’ exact performance requirements each and every time." -Aidan O’Sullivan, vice president of operations at Shapeways. Next-generation Additive Manufacturing Is Powered by World-class Quality Quality professionals at each Shapeways ISO-9001 manufacturing facility adhere to stringent quality assurance and quality control methods that include everything from prototypes to full-scale production of high-performance, end-use components. In addition, an experienced user-application group aids clients in defining design features and directing material and technology combinations that result in the best potential outcomes for several industrial applications in the aerospace and military, automotive, and healthcare industries. Additionally, Shapeways meets the rising demand for highly customized items by tailoring its quality management system to various stringent needs. For instance, Shapeways collaborates with an international producer of bespoke knee braces to create two things with distinct activity levels. Shapeways discovered precise file orientations and stress-testing techniques to help assure the most significant levels of product dependability and performance. Additionally, the user-application team advised that Nylon 11 material be used to construct a brace type tailored explicitly for high-impact sporting performance.Additionally, Shapeways collaborates directly with clients such as 67 Designs, a manufacturer of rugged iPad mounts for off-roading, to optimize builds and scale production quantities at prices equivalent to traditional injection molding. Real-time Monitoring, Testing, and Traceability Shapeways' multi-step quality control method incorporates real-time monitoring and notifications, as well as comprehensive testing and quality checks to ensure the dependability and uniformity of each product. In addition, tracking updates on all manufacturing and post-processing operations keep customers fully informed of progress. At the same time, total traceability enables rapid root-cause investigation of issues affecting end-to-end manufacturing flows. When manufacturing high-quality drone components for many Shapeways industrial clients, the quality team subjected each component to strict strength criteria to ensure maximum longevity. Additionally, they worked with drone clients to match the part design and file orientations with the varied needs for drone assembly in the United States, Europe, and Asia. Additionally, Shapeways collaborates closely with its worldwide network of technology and manufacturing partners via dynamic feedback loops to optimize operating efficiency and expedite preventative maintenance. Shapeways will continue to extend its capabilities as it grows operations to meet the ever-increasing needs of Additive Manufacturing 2.0, including the invention of new quality control methods for specific industrial uses. *Certain statements in this news release are not historical facts and include forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995's safe harbor protections.

Read More

MANUFACTURING TECHNOLOGY

MVP Releases New Model of its Reactive Additive Manufacturing (RAM) System for Thermoset Materials

Magnum Venus Products | October 19, 2021

Magnum Venus Products (MVP), a global manufacturer of fluid movement and production solutions for industrial applications, is launching a new model of its Reactive Additive Manufacturing (RAM) system to enable cost-effective fabrication of thermoset materials at medium- and large-scale. The new model, named RAM 48, has a print area of four-by-eight-feet with modular, expandable four-by-four-foot sections to allow for custom build dimensions. Since the launch of the RAM system in 2019, MVP has discovered new applications for this technology, and it designed RAM 48 to complement its original RAM 816 model and take full advantage of these breakthroughs. "Thermosets, or plastics which cannot be remelted, have long been used in injection and compression molding, but we are just beginning to harness the potential of 3d printing with thermosets," says Mike Kastura, Director of Product Management at MVP. Thermosets contain polymers which chemically react in the curing process, cross linking between printed layers to form a powerful bond, and resulting in stronger, more heat-tolerant products. These inherent properties of thermoset materials enable printing with open layer times, which creates the ability to pick-and-place items into the print, such as heating channels or sensors to monitor part specifications. Another benefit is the ability print multiple parts simultaneously, and to print through a previous path, allowing more complex designs than ever before. Thermosets also enable secondary bonding of materials, making it easier and faster to achieve a class-A surface finish, join two parts, or quickly repair a damaged mold. We are excited to continue to innovate and develop disruptive technologies in the additive manufacturing landscape,Developments like these will alter the way our customers operate by giving them the right tools to maximize production efficiency and build better, higher-quality products. Andrew Hedger, Senior Director of Business Development at MVP The RAM 48 model is already making waves in the additive industry. Mississippi State University Advanced Composites Institutes recently placed a pre-order for the new RAM 48 model and plans to develop transformative composite technologies for its industry partners utilizing the RAM system. Developed in collaboration with scientists at Oak Ridge National Laboratory (ORNL), the RAM system was the first to successfully produce large-scale prints of thermoset materials. Polynt-Reichhold designed a specialty print media to use in the RAM system, PRD-1520. The team earned a CAMX ACE award in 2019 and is once again a finalist this year for developing a novel method to produce unsupported 90-degree overhangs in large-scale thermoset printing. Visit the MVP booth (AA28) at CAMX to view 3d printed thermoset molds currently used in the industry. About MVP: CAMX booth AA28 Magnum Venus Products (MVP) is a global manufacturer of fluid movement and production solutions for industrial applications in composites and adhesives markets. MVP collaborates with its customers to offer tailored production solutions to meter, mix, dispense, and apply materials. For over 80 years, MVP has been a leading equipment provider for the marine, infrastructure, pool and bath, oil & gas, transportation, aerospace, and wind industries.

Read More

Therapure Biomanufacturing Signs Manufacturing Deal With VBI Vaccines for Coronavirus Vaccine Candidates

VBI VACCINES | August 24, 2020

Therapure Biomanufacturing, a division of Therapure Biopharma Inc., announced today the signing of an agreement with VBI Vaccines Inc. for the manufacture of their coronavirus vaccine candidates. Therapure Biomanufacturing is an integrated contract development and manufacturing organization focused on biologic and high value therapeutics that can provide new options for patient care. Under this agreement, Therapure will be responsible for the biomanufacturing of the vaccine drug substance as well as the aseptic fill of the drug product at the Therapure facility in Mississauga, Ontario. Mr. Safa’a Al-Rais, Therapure’s Chief Operating Officer, said: “We are delighted to partner with VBI to assist with providing an effective response to the ongoing COVID-19 pandemic through Therapure’s biomanufacturing and aseptic fill finish services for VBI’s innovative COVID-19 vaccine candidates, which utilize their flexible enveloped virus-like particle (eVLP) platform technology. Therapure prides itself on its development, clinical and commercial cGMP manufacturing expertise providing solutions for biologic therapeutics and innovative drug delivery technologies, which make a difference in patients’ lives.”

Read More